540 related articles for article (PubMed ID: 16278162)
1. Stem cell-based therapy for Parkinson's disease.
Correia AS; Anisimov SV; Li JY; Brundin P
Ann Med; 2005; 37(7):487-98. PubMed ID: 16278162
[TBL] [Abstract][Full Text] [Related]
2. From bench to bed: the potential of stem cells for the treatment of Parkinson's disease.
Morizane A; Li JY; Brundin P
Cell Tissue Res; 2008 Jan; 331(1):323-36. PubMed ID: 18034267
[TBL] [Abstract][Full Text] [Related]
3. Regenerative medicine in Parkinson's disease: generation of mesencephalic dopaminergic cells from embryonic stem cells.
Taylor H; Minger SL
Curr Opin Biotechnol; 2005 Oct; 16(5):487-92. PubMed ID: 16143504
[TBL] [Abstract][Full Text] [Related]
4. Transplantation of embryonic stem cell-derived dopaminergic neurons in MPTP-treated monkeys.
Takahashi J; Takagi Y; Saiki H
Methods Mol Biol; 2009; 482():199-212. PubMed ID: 19089358
[TBL] [Abstract][Full Text] [Related]
5. The role of Lmx1a in the differentiation of human embryonic stem cells into midbrain dopamine neurons in culture and after transplantation into a Parkinson's disease model.
Cai J; Donaldson A; Yang M; German MS; Enikolopov G; Iacovitti L
Stem Cells; 2009 Jan; 27(1):220-9. PubMed ID: 18832589
[TBL] [Abstract][Full Text] [Related]
6. Olfactory mucosa is a potential source for autologous stem cell therapy for Parkinson's disease.
Murrell W; Wetzig A; Donnellan M; Féron F; Burne T; Meedeniya A; Kesby J; Bianco J; Perry C; Silburn P; Mackay-Sim A
Stem Cells; 2008 Aug; 26(8):2183-92. PubMed ID: 18535154
[TBL] [Abstract][Full Text] [Related]
7. The search for a curative cell therapy in Parkinson's disease.
Laguna Goya R; Tyers P; Barker RA
J Neurol Sci; 2008 Feb; 265(1-2):32-42. PubMed ID: 17936303
[TBL] [Abstract][Full Text] [Related]
8. Pluripotent stem cells as new drugs? The example of Parkinson's disease.
Preynat-Seauve O; Burkhard PR; Villard J; Zingg W; Ginovart N; Feki A; Dubois-Dauphin M; Hurst SA; Mauron A; Jaconi M; Krause KH
Int J Pharm; 2009 Nov; 381(2):113-21. PubMed ID: 19782880
[TBL] [Abstract][Full Text] [Related]
9. Dopamine neurons derived from embryonic stem cells function in an animal model of Parkinson's disease.
Kim JH; Auerbach JM; Rodríguez-Gómez JA; Velasco I; Gavin D; Lumelsky N; Lee SH; Nguyen J; Sánchez-Pernaute R; Bankiewicz K; McKay R
Nature; 2002 Jul; 418(6893):50-6. PubMed ID: 12077607
[TBL] [Abstract][Full Text] [Related]
10. Autologous neural stem cell transplantation: a new treatment option for Parkinson's disease?
Arias-Carrión O; Yuan TF
Med Hypotheses; 2009 Nov; 73(5):757-9. PubMed ID: 19467573
[TBL] [Abstract][Full Text] [Related]
11. Neural grafting in Parkinson's disease Problems and possibilities.
Brundin P; Barker RA; Parmar M
Prog Brain Res; 2010; 184():265-94. PubMed ID: 20887880
[TBL] [Abstract][Full Text] [Related]
12. Cell therapy for Parkinson's disease: problems and prospects.
Björklund A
Novartis Found Symp; 2005; 265():174-86; discussion 187, 204-211. PubMed ID: 16050257
[TBL] [Abstract][Full Text] [Related]
13. Toward full restoration of synaptic and terminal function of the dopaminergic system in Parkinson's disease by stem cells.
Isacson O; Bjorklund LM; Schumacher JM
Ann Neurol; 2003; 53 Suppl 3():S135-46; discussion S146-8. PubMed ID: 12666105
[TBL] [Abstract][Full Text] [Related]
14. Derivation of functional dopamine neurons from embryonic stem cells.
Kim DS; Kim JY; Kang M; Cho MS; Kim DW
Cell Transplant; 2007; 16(2):117-23. PubMed ID: 17474293
[TBL] [Abstract][Full Text] [Related]
15. Dopaminergic properties and function after grafting of attached neural precursor cultures.
Timmer M; Grosskreutz J; Schlesinger F; Krampfl K; Wesemann M; Just L; Bufler J; Grothe C
Neurobiol Dis; 2006 Mar; 21(3):587-606. PubMed ID: 16256357
[TBL] [Abstract][Full Text] [Related]
16. Stem cell therapy for Parkinson's disease.
Takahashi J
Expert Rev Neurother; 2007 Jun; 7(6):667-75. PubMed ID: 17563250
[TBL] [Abstract][Full Text] [Related]
17. In-vitro analysis of Pitx3 in mesodiencephalic dopaminergic neuron maturation.
Papanikolaou T; Amano T; Lennington J; Sink K; Farrar AM; Salamone J; Yang X; Conover JC
Eur J Neurosci; 2009 Jun; 29(12):2264-75. PubMed ID: 19508691
[TBL] [Abstract][Full Text] [Related]
18. Neuronal cell replacement in Parkinson's disease.
Hedlund E; Perlmann T
J Intern Med; 2009 Oct; 266(4):358-71. PubMed ID: 19765180
[TBL] [Abstract][Full Text] [Related]
19. Cripto as a target for improving embryonic stem cell-based therapy in Parkinson's disease.
Parish CL; Parisi S; Persico MG; Arenas E; Minchiotti G
Stem Cells; 2005 Apr; 23(4):471-6. PubMed ID: 15790767
[TBL] [Abstract][Full Text] [Related]
20. Cell-based therapies for Parkinson's disease.
Dyson SC; Barker RA
Expert Rev Neurother; 2011 Jun; 11(6):831-44. PubMed ID: 21651331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
